ID   GUAA_HUMAN              Reviewed;         693 AA.
AC   P49915; A8K639; B4DXV7; F8W720;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   15-MAR-2017, entry version 177.
DE   RecName: Full=GMP synthase [glutamine-hydrolyzing];
DE            EC=6.3.5.2;
DE   AltName: Full=GMP synthetase;
DE   AltName: Full=Glutamine amidotransferase;
GN   Name=GMPS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=8089153;
RA   Hirst M., Haliday E., Nakamura J., Lou L.;
RT   "Human GMP synthetase. Protein purification, cloning, and functional
RT   expression of cDNA.";
RL   J. Biol. Chem. 269:23830-23837(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHROMOSOMAL TRANSLOCATION WITH KMT2A/MLL1.
RX   PubMed=11110714;
RA   Pegram L.D., Megonigal M.D., Lange B.J., Nowell P.C., Rowley J.D.,
RA   Rappaport E.F., Felix C.A.;
RT   "t(3;11) translocation in treatment-related acute myeloid leukemia
RT   fuses MLL with the GMPS (guanosine 5-prime monophosphate synthetase)
RT   gene.";
RL   Blood 96:4360-4362(2000).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-9, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-318 AND SER-332, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8 AND SER-332, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 20-693, SUBSTRATE-BINDING
RP   SITES, ACTIVE SITE, AND SUBUNIT.
RX   PubMed=23816837; DOI=10.1016/j.jmb.2013.06.032;
RA   Welin M., Lehtio L., Johansson A., Flodin S., Nyman T., Tresaugues L.,
RA   Hammarstrom M., Graslund S., Nordlund P.;
RT   "Substrate specificity and oligomerization of human GMP synthetase.";
RL   J. Mol. Biol. 425:4323-4333(2013).
CC   -!- FUNCTION: Involved in the de novo synthesis of guanine nucleotides
CC       which are not only essential for DNA and RNA synthesis, but also
CC       provide GTP, which is involved in a number of cellular processes
CC       important for cell division.
CC   -!- CATALYTIC ACTIVITY: ATP + XMP + L-glutamine + H(2)O = AMP +
CC       diphosphate + GMP + L-glutamate.
CC   -!- PATHWAY: Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln
CC       route): step 1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:23816837}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49915-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49915-2; Sequence=VSP_053933;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Note=A chromosomal aberration involving GMPS is found in
CC       acute myeloid leukemias. Translocation t(3,11)(q25,q23) with
CC       KMT2A/MLL1.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GMPSID229.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U10860; AAA60331.1; -; mRNA.
DR   EMBL; AK291504; BAF84193.1; -; mRNA.
DR   EMBL; AK302148; BAG63519.1; -; mRNA.
DR   EMBL; AK315832; BAF98723.1; -; mRNA.
DR   EMBL; AC067721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104472; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC140753; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78741.1; -; Genomic_DNA.
DR   EMBL; BC012178; AAH12178.1; -; mRNA.
DR   CCDS; CCDS46941.1; -. [P49915-1]
DR   PIR; A54847; A54847.
DR   RefSeq; NP_003866.1; NM_003875.2. [P49915-1]
DR   UniGene; Hs.591314; -.
DR   PDB; 2VPI; X-ray; 2.40 A; A/B=25-219.
DR   PDB; 2VXO; X-ray; 2.50 A; A/B=20-693.
DR   PDBsum; 2VPI; -.
DR   PDBsum; 2VXO; -.
DR   ProteinModelPortal; P49915; -.
DR   SMR; P49915; -.
DR   BioGrid; 114360; 46.
DR   IntAct; P49915; 23.
DR   MINT; MINT-5004310; -.
DR   STRING; 9606.ENSP00000419851; -.
DR   ChEMBL; CHEMBL5721; -.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00130; L-Glutamine.
DR   MEROPS; C26.950; -.
DR   iPTMnet; P49915; -.
DR   PhosphoSitePlus; P49915; -.
DR   SwissPalm; P49915; -.
DR   BioMuta; GMPS; -.
DR   DMDM; 1708072; -.
DR   REPRODUCTION-2DPAGE; IPI00029079; -.
DR   EPD; P49915; -.
DR   MaxQB; P49915; -.
DR   PaxDb; P49915; -.
DR   PeptideAtlas; P49915; -.
DR   PRIDE; P49915; -.
DR   DNASU; 8833; -.
DR   Ensembl; ENST00000295920; ENSP00000295920; ENSG00000163655. [P49915-2]
DR   Ensembl; ENST00000496455; ENSP00000419851; ENSG00000163655. [P49915-1]
DR   GeneID; 8833; -.
DR   KEGG; hsa:8833; -.
DR   UCSC; uc003faq.4; human. [P49915-1]
DR   CTD; 8833; -.
DR   DisGeNET; 8833; -.
DR   GeneCards; GMPS; -.
DR   HGNC; HGNC:4378; GMPS.
DR   HPA; HPA046630; -.
DR   MalaCards; GMPS; -.
DR   MIM; 600358; gene.
DR   neXtProt; NX_P49915; -.
DR   OpenTargets; ENSG00000163655; -.
DR   PharmGKB; PA28763; -.
DR   eggNOG; KOG1622; Eukaryota.
DR   eggNOG; COG0518; LUCA.
DR   eggNOG; COG0519; LUCA.
DR   GeneTree; ENSGT00390000006591; -.
DR   HOGENOM; HOG000223965; -.
DR   HOVERGEN; HBG005929; -.
DR   InParanoid; P49915; -.
DR   KO; K01951; -.
DR   OMA; NMTTNPE; -.
DR   OrthoDB; EOG091G031G; -.
DR   PhylomeDB; P49915; -.
DR   TreeFam; TF106132; -.
DR   BRENDA; 6.3.5.2; 2681.
DR   Reactome; R-HSA-73817; Purine ribonucleoside monophosphate biosynthesis.
DR   SIGNOR; P49915; -.
DR   UniPathway; UPA00189; UER00296.
DR   ChiTaRS; GMPS; human.
DR   EvolutionaryTrace; P49915; -.
DR   GeneWiki; GMP_synthase; -.
DR   GenomeRNAi; 8833; -.
DR   PRO; PR:P49915; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163655; -.
DR   CleanEx; HS_GMPS; -.
DR   ExpressionAtlas; P49915; baseline and differential.
DR   Genevisible; P49915; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003922; F:GMP synthase (glutamine-hydrolyzing) activity; IBA:GO_Central.
DR   GO; GO:0003921; F:GMP synthase activity; EXP:Reactome.
DR   GO; GO:0016462; F:pyrophosphatase activity; IEA:InterPro.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006177; P:GMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0009113; P:purine nucleobase biosynthetic process; TAS:ProtInc.
DR   GO; GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome.
DR   CDD; cd01742; GATase1_GMP_Synthase; 1.
DR   CDD; cd01997; GMP_synthase_C; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   Gene3D; 3.40.50.880; -; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR001674; GMP_synth_C.
DR   InterPro; IPR004739; GMP_synth_GATase.
DR   InterPro; IPR025777; GMPS_ATP_PPase_dom.
DR   InterPro; IPR022310; NAD/GMP_synthase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00117; GATase; 1.
DR   Pfam; PF00958; GMP_synt_C; 1.
DR   Pfam; PF02540; NAD_synthase; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   TIGRFAMs; TIGR00888; guaA_Nterm; 1.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
DR   PROSITE; PS51553; GMPS_ATP_PPASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Glutamine amidotransferase;
KW   GMP biosynthesis; Ligase; Nucleotide-binding; Phosphoprotein;
KW   Proto-oncogene; Purine biosynthesis; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    693       GMP synthase [glutamine-hydrolyzing].
FT                                /FTId=PRO_0000140257.
FT   DOMAIN       27    216       Glutamine amidotransferase type-1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00605}.
FT   DOMAIN      217    435       GMPS ATP-PPase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00886}.
FT   NP_BIND     244    250       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00886}.
FT   ACT_SITE    104    104       For GATase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00605,
FT                                ECO:0000269|PubMed:23816837}.
FT   ACT_SITE    190    190       For GATase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00605,
FT                                ECO:0000269|PubMed:23816837}.
FT   ACT_SITE    192    192       For GATase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00605,
FT                                ECO:0000269|PubMed:23816837}.
FT   BINDING     337    337       Substrate.
FT   BINDING     522    522       Substrate.
FT   BINDING     610    610       Substrate.
FT   BINDING     685    685       Substrate.
FT   BINDING     691    691       Substrate.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES       8      8       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES       9      9       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     318    318       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     332    332       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      10    108       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053933.
FT   CONFLICT    261    261       N -> D (in Ref. 2; BAG63519).
FT                                {ECO:0000305}.
FT   CONFLICT    415    415       H -> I (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       28     32       {ECO:0000244|PDB:2VPI}.
FT   TURN         35     38       {ECO:0000244|PDB:2VPI}.
FT   HELIX        39     47       {ECO:0000244|PDB:2VPI}.
FT   STRAND       52     54       {ECO:0000244|PDB:2VPI}.
FT   HELIX        61     67       {ECO:0000244|PDB:2VPI}.
FT   STRAND       70     76       {ECO:0000244|PDB:2VPI}.
FT   HELIX        91     94       {ECO:0000244|PDB:2VPI}.
FT   STRAND      100    104       {ECO:0000244|PDB:2VPI}.
FT   HELIX       105    113       {ECO:0000244|PDB:2VPI}.
FT   STRAND      118    123       {ECO:0000244|PDB:2VPI}.
FT   STRAND      127    133       {ECO:0000244|PDB:2VPI}.
FT   HELIX       138    140       {ECO:0000244|PDB:2VPI}.
FT   STRAND      145    151       {ECO:0000244|PDB:2VPI}.
FT   STRAND      153    159       {ECO:0000244|PDB:2VPI}.
FT   STRAND      165    170       {ECO:0000244|PDB:2VPI}.
FT   STRAND      173    179       {ECO:0000244|PDB:2VPI}.
FT   TURN        180    183       {ECO:0000244|PDB:2VPI}.
FT   STRAND      184    189       {ECO:0000244|PDB:2VPI}.
FT   STRAND      193    196       {ECO:0000244|PDB:2VXO}.
FT   HELIX       199    207       {ECO:0000244|PDB:2VPI}.
FT   TURN        208    211       {ECO:0000244|PDB:2VPI}.
FT   HELIX       219    234       {ECO:0000244|PDB:2VXO}.
FT   STRAND      238    242       {ECO:0000244|PDB:2VXO}.
FT   HELIX       247    259       {ECO:0000244|PDB:2VXO}.
FT   HELIX       262    264       {ECO:0000244|PDB:2VXO}.
FT   STRAND      265    271       {ECO:0000244|PDB:2VXO}.
FT   HELIX       281    289       {ECO:0000244|PDB:2VXO}.
FT   STRAND      294    298       {ECO:0000244|PDB:2VXO}.
FT   HELIX       300    304       {ECO:0000244|PDB:2VXO}.
FT   HELIX       327    329       {ECO:0000244|PDB:2VXO}.
FT   HELIX       333    354       {ECO:0000244|PDB:2VXO}.
FT   STRAND      361    365       {ECO:0000244|PDB:2VXO}.
FT   HELIX       377    382       {ECO:0000244|PDB:2VXO}.
FT   HELIX       387    389       {ECO:0000244|PDB:2VXO}.
FT   HELIX       396    403       {ECO:0000244|PDB:2VXO}.
FT   HELIX       410    413       {ECO:0000244|PDB:2VXO}.
FT   HELIX       416    425       {ECO:0000244|PDB:2VXO}.
FT   HELIX       430    433       {ECO:0000244|PDB:2VXO}.
FT   HELIX       442    446       {ECO:0000244|PDB:2VXO}.
FT   STRAND      450    452       {ECO:0000244|PDB:2VXO}.
FT   HELIX       459    470       {ECO:0000244|PDB:2VXO}.
FT   HELIX       472    475       {ECO:0000244|PDB:2VXO}.
FT   HELIX       481    489       {ECO:0000244|PDB:2VXO}.
FT   HELIX       492    504       {ECO:0000244|PDB:2VXO}.
FT   STRAND      507    520       {ECO:0000244|PDB:2VXO}.
FT   STRAND      523    536       {ECO:0000244|PDB:2VXO}.
FT   HELIX       540    553       {ECO:0000244|PDB:2VXO}.
FT   STRAND      557    563       {ECO:0000244|PDB:2VXO}.
FT   HELIX       582    601       {ECO:0000244|PDB:2VXO}.
FT   HELIX       605    607       {ECO:0000244|PDB:2VXO}.
FT   STRAND      613    617       {ECO:0000244|PDB:2VXO}.
FT   HELIX       624    626       {ECO:0000244|PDB:2VXO}.
FT   STRAND      633    637       {ECO:0000244|PDB:2VXO}.
FT   STRAND      643    649       {ECO:0000244|PDB:2VXO}.
FT   TURN        654    656       {ECO:0000244|PDB:2VXO}.
FT   HELIX       659    671       {ECO:0000244|PDB:2VXO}.
FT   STRAND      675    681       {ECO:0000244|PDB:2VXO}.
SQ   SEQUENCE   693 AA;  76715 MW;  1CDA0DD3B244728D CRC64;
     MALCNGDSKL ENAGGDLKDG HHHYEGAVVI LDAGAQYGKV IDRRVRELFV QSEIFPLETP
     AFAIKEQGFR AIIISGGPNS VYAEDAPWFD PAIFTIGKPV LGICYGMQMM NKVFGGTVHK
     KSVREDGVFN ISVDNTCSLF RGLQKEEVVL LTHGDSVDKV ADGFKVVARS GNIVAGIANE
     SKKLYGAQFH PEVGLTENGK VILKNFLYDI AGCSGTFTVQ NRELECIREI KERVGTSKVL
     VLLSGGVDST VCTALLNRAL NQEQVIAVHI DNGFMRKRES QSVEEALKKL GIQVKVINAA
     HSFYNGTTTL PISDEDRTPR KRISKTLNMT TSPEEKRKII GDTFVKIANE VIGEMNLKPE
     EVFLAQGTLR PDLIESASLV ASGKAELIKT HHNDTELIRK LREEGKVIEP LKDFHKDEVR
     ILGRELGLPE ELVSRHPFPG PGLAIRVICA EEPYICKDFP ETNNILKIVA DFSASVKKPH
     TLLQRVKACT TEEDQEKLMQ ITSLHSLNAF LLPIKTVGVQ GDCRSYSYVC GISSKDEPDW
     ESLIFLARLI PRMCHNVNRV VYIFGPPVKE PPTDVTPTFL TTGVLSTLRQ ADFEAHNILR
     ESGYAGKISQ MPVILTPLHF DRDPLQKQPS CQRSVVIRTF ITSDFMTGIP ATPGNEIPVE
     VVLKMVTEIK KIPGISRIMY DLTSKPPGTT EWE
//
